Gwph price target
WebGWPH . Coverage Performance Price Targets & Ratings Chart. with average potential upside of $48.77 (43.48%) backed by 59 price targets and 53 ratings. Documented since … WebJun 24, 2024 · With 30.6M shares outstanding and a further 1.2M shares of options, the fully diluted market cap for GWPH is approximately $5.6B (assuming a price of $176). GWPH is thus trading at 5.6 x 2024 ...
Gwph price target
Did you know?
WebMay 3, 2024 · GW Pharmaceuticals Ltd is a United Kingdom-based company that operates as a biopharmaceutical company. The Company manufactures pharmaceutical products. The Company specializes in developing, processing, and manufacturing drugs in pharmaceutical preparations for human and veterinary uses. The Company serves … WebGWPH: NA broker reports. Get the latest broker reports from Zacks Investment Research. ... Initiate at Buy With $170 Price Target. Provider: H.C. Wainwright & Co., Inc. Analyst: TSAO D.
WebJan 2, 2024 · There are a total of 15 analysts that cover GW Pharmaceuticals as of December 24, 2024. Of those analysts 5 rate the company a “strong-buy,” and 10 rate it as a “buy.” The analysts have an average price target of $206.07 on the company which offers almost 100% upside from current levels. Three analysts, in particular, caught our attention. WebThe Fed’s preferred measure of inflation—the personal-consumption expenditures price index—rose 6.8% in June from the same month a year earlier. That was far above the central bank’s target and the sharpest rise since January 1982. Investors will see the July reading later this month.
WebStock Target Advisor’s own stock analysis of GW Pharmaceuticals plc is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, GW Pharmaceuticals plc’s stock price was USD 218.96. GW Pharmaceuticals plc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the ... WebThere is no chart data available for this period. 1d 1w 1m 3m 6m 1y All. Current Price. $219.16. Prev Close. $219.28. Open. $219.53. Dividend Yield.
WebApr 3, 2024 · finance.yahoo.com - October 26 at 9:58 AM. Jazz Pharmaceuticals Q2 Revenue Jumps 34% To $751.8M With $109.5M Epidiolex Net Sales, Reaffirms Its 2024 …
WebGWPH's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. Home Guide ... Price target upside according to sell-side analysts. Quant Recommendation - GWPH. Ratings analysis incomplete due to data availability. Recommendations not provided. mab aesthetic shopWebFeb 3, 2024 · This will have it paying $200 in cash and $20 in JAZZ stock for each share of GWPH stock. The number of JAZZ shares used in the acquisition will be calculated based on the price of the stock over ... mabae hair reviewsWebJun 4, 2024 · Adjusting for the difference in cash/debt, I would target somewhere around $6.5 billion for GWPH. This would represent 44% upside or a price target of around $234 per share. mab affinityWebGWPH : 218.96 (-0.15%) JAZZ : 147.16 (+0.95%) GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex Globe NewsWire - Tue Apr 20, 2024. – Tuberous sclerosis complex (TSC) represents a third indication for GW’s cannabidiol in … mabagal lyrics chordsWebMay 5, 2024 · May 05, 2024. DUBLIN, May 5, 2024 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines. "We are excited to welcome our GW … maba frameworkWebJul 16, 2024 · GW Pharmaceuticals (NASDAQ:GWPH) has a market capitalization of $6.86 billion and generates $311.33 million in revenue each year. The biopharmaceutical … kitchenaid 6 quart lift stand mixerkitchenaid 6-quart flex edge beater